CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556 · see citing works

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668 · see citing works

A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · see citing works

The landscape of somatic copy-number alteration across human cancers

Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017 · see citing works

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969 · see citing works

NGS QC Toolkit: A Toolkit for Quality Control of Next Generation Sequencing Data

Patel, R. K., & Jain, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030619 · Cited by 2,921 · see citing works

Whole genomes redefine the mutational landscape of pancreatic cancer

Initiative, A. P. C. G., Waddell, N., Pajic, M., Patch, A.-M., Chang, D. K., Kassahn, K. S., Bailey, P., Johns, A. L., Miller, D., Nones, K., et al. (2015) · Nature · doi:10.1038/nature14169 · Cited by 2,642 · see citing works

Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice

Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609 · see citing works

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471 · see citing works

Pancreatic adenocarcinoma

Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348 · see citing works

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058 · see citing works

Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-rasPreprint

Jackson, E. L., Willis, N. A., Mercer, K. L., Bronson, R. T., Crowley, D. G., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,877 · see citing works

Role of the INK4a Locus in Tumor Suppression and Cell Mortality

Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585 · see citing works

Genetics and biology of pancreatic ductal adenocarcinomaPreprint

Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N. M., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,570 · see citing works

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Witkiewicz, A. K., McMillan, E. A., Balaji, U., Baek, G., Lin, W.-C., Mansour, J., Mollaee, M., Wagner, K.-U., Koduru, P., Yopp, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7744 · Cited by 1,115 · see citing works

Activated Kras and <i>Ink4a/Arf</i> deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., & DePinho, R. A. (2003) · Genes &amp; Development · doi:10.1101/gad.1158703 · Cited by 1,033 · see citing works

Signatures of mutation and selection in the cancer genome

Bignell, G. R., Greenman, C. D., Davies, H., Butler, A. P., Edkins, S., Andrews, J. M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08768 · Cited by 707 · see citing works

Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma

Kopp, J. L., von Figura, G., Mayes, E., Liu, F.-F., Dubois, C. L., Morris, J. P., Pan, F. C., Akiyama, H., Wright, C. V. E., Jensen, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.025 · Cited by 697 · see citing works

Both p16 Ink4a and the p19 Arf -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse

Bardeesy, N. M., Aguirre, A. J., Chu, G. C., Cheng, K., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C. W., Weissleder, R., Mahmood, U., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601273103 · Cited by 575 · see citing works

Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice

Friedmann‐Morvinski, D., Bushong, E. A., Ke, E., Soda, Y., Marumoto, T., Singer, O., Ellisman, M. H., & Verma, I. M. (2012) · Science · doi:10.1126/science.1226929 · Cited by 566 · see citing works

Genetics and biology of pancreatic ductal adenocarcinoma

Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., & DePinho, R. A. (2016) · Genes &amp; Development · doi:10.1101/gad.275776.115 · Cited by 527 · see citing works

Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence

Guerra, C., Collado, M., Navas, C., Schuhmacher, A. J., Hernández-Porras, I., Cañamero, M., Rodriguez-Justo, M., Serrano, M., & Barbacid, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.011 · Cited by 516 · see citing works

TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b

Seoane, J., Pouponnot, C., Staller, P., Schader, M. B., Eilers, M., & Massagué, J. (2001) · Nature Cell Biology · doi:10.1038/35070086 · Cited by 489 · see citing works

Anesthesia and Analgesia in Laboratory Animals

(1997) · Elsevier eBooks · doi:10.1016/b978-0-12-417570-9.x5000-4 · Cited by 422 · see citing works

Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice

Habbe, N., Shi, G., Meguid, R. A., Fendrich, V., Esni, F., Chen, H., Feldmann, G., Stoffers, D. A., Konieczny, S. F., Leach, S. D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810097105 · Cited by 410 · see citing works

Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF‐β

Feng, X., Lin, X., & Derynck, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5178 · Cited by 397 · see citing works

Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.

Morris, J. P., Cano, D., Sekine, S., Wang, S. C., & Hebrok, M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40045 · Cited by 391 · see citing works

Generation of a germ cell‐specific mouse transgenic Cre line, Vasa‐Cre

Gallardo, T. D., Shirley, L. J., John, G. B., & Castrillón, D. H. (2007) · genesis · doi:10.1002/dvg.20310 · Cited by 366 · see citing works

The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin

Baron, V. T., Adamson, E. D., Calogero, A., Ragona, G., & Mercola, D. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700896 · Cited by 345 · see citing works

Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras

Friedlander, S., Chu, G. C., Snyder, E. L., Girnius, N., Dibelius, G., Crowley, D. G., Vasile, E., DePinho, R. A., & Jacks, T. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.027 · Cited by 338 · see citing works

p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a

Krimpenfort, P., IJpenberg, A., Song, J.-Y., van der Valk, M., Nawijn, M., Zevenhoven, J., & Berns, A. (2007) · Nature · doi:10.1038/nature06084 · Cited by 269 · see citing works

Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesis

Latres, E., Malumbres, M., Sotillo, R., Martín, J., Ortega, S., Martín‐Caballero, J., Flores, J. M., Cordón‐Cardo, C., & Barbacid, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3496 · Cited by 257 · see citing works

Ras Activity Levels Control the Development of Pancreatic Diseases

Ji, B., Tsou, L., Wang, H., Gaiser, S., Chang, D. Z., Daniluk, J., Bi, Y., Grote, T., Longnecker, D. S., & Logsdon, C. D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.052 · Cited by 194 · see citing works

Genetically engineered mouse models of pancreatic adenocarcinoma

Guerra, C. E., & Barbacid, M. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.002 · Cited by 179 · see citing works

p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells

Bailey, J. M., Hendley, A. M., Lafaro, K. J., Pruski, M. A., Jones, N. C., Alsina, J., Younes, M., Maitra, A., McAllister, F., Iacobuzio-Donahue, C. A., et al. (2016) · Oncogene · doi:10.1038/onc.2015.441 · Cited by 154 · see citing works

GEMMs as preclinical models for testing pancreatic cancer therapies

Gopinathan, A., Morton, J. P., Jodrell, D. I., & Sansom, O. J. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.021055 · Cited by 139 · see citing works

Repression of transforming-growth-factor-β-mediated transcription by nuclear factor κB

Nagarajan, R. P., Feifei, C. H. E. N., Li, W., Vig, E., Harrington, M. A., Nakshatri, H., & Chen, Y. (2000) · Biochemical Journal · doi:10.1042/bj3480591 · Cited by 123 · see citing works

Whole-exome sequencing of human pancreatic cancers and characterization of genomic instability caused by MLH1 haploinsufficiency and complete deficiencyPreprint

Wang, L., Tsutsumi, S., Kawaguchi, T., Nagasaki, K., Tatsuno, K., Yamamoto, S., Sang, F., Sonoda, K., Sugawara, M., Saiura, A., et al. (2011) · Genome Research · doi:10.1101/gr.123109.111 · Cited by 120 · see citing works

Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.

Nagarajan, R. P., Chen, F., Li, W., Vig, E., Harrington, M. A., Nakshatri, H., & Chen, Y. (2000) · PubMed Central · Cited by 117 · see citing works

The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-β1, Fibronectin, and Plasminogen Activator Inhibitor-1

Liu, C., Yao, J. J., de Belle, I., Huang, R., Adamson, E. D., & Mercola, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.7.4400 · Cited by 111 · see citing works

CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma

McNeal, A. S., Liu, K., Nakhate, V., Natale, C. A., Duperret, E. K., Capell, B. C., Dentchev, T., Berger, S. L., Herlyn, M., Seykora, J. T., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0196 · Cited by 92 · see citing works

Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis

Niola, F., Zhao, X., Singh, D., Sullivan, R. J., Castano, A. M., Verrico, A., Zoppoli, P., Friedmann‐Morvinski, D., Sulman, E. P., Barrett, L. E., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63811 · Cited by 76 · see citing works

Ras-Induced Senescence and its Physiological Relevance in Cancer

DiMauro, T., & David, G. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357998 · Cited by 74 · see citing works

The keratin 19 promoter is potent for cell-specific targeting of genes in transgenic mice

Brembeck, F. H., Moffett, J., Wang, T. C., & Rustgi, A. K. (2001) · Gastroenterology · doi:10.1053/gast.2001.24846 · Cited by 67 · see citing works

Optimization of lentiviral vector production using polyethylenimine-mediated transfection

Tang, Y., Garson, K., Li, L., & Vanderhyden, B. C. (2014) · Oncology Letters · doi:10.3892/ol.2014.2684 · Cited by 63 · see citing works

Ras Activity in Acinar Cells Links Chronic Pancreatitis and Pancreatic Cancer

Logsdon, C. D., & Ji, B. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.040 · Cited by 57 · see citing works

Nullifying the CDKN2AB Locus Promotes Mutant K-ras Lung Tumorigenesis

Schuster, K., Venkateswaran, N., Rabellino, A., Girard, L., Peña‐Llopis, S., & Scaglioni, P. P. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0620-t · Cited by 43 · see citing works

Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics

Singh, S. K., & Ellenrieder, V. (2013) · Gut · doi:10.1136/gutjnl-2012-302793 · Cited by 28 · see citing works

Gene delivery to pancreatic exocrine cells in vivo and in vitro

Houbracken, I., Baeyens, L., Ravassard, P., Heimberg, H., & Bouwens, L. (2012) · BMC Biotechnology · doi:10.1186/1472-6750-12-74 · Cited by 17 · see citing works

Mature acinar cells are refractory to carcinoma development by targeted activation of Ras oncogene in adult rats

Tanaka, H., Fukamachi, K., Futakuchi, M., Alexander, D. B., Long, N., Tamamushi, S., Minami, K., Seino, S., Ohara, H., Joh, T., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01410.x · Cited by 16 · see citing works

ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype

Ben‐Chetrit, N., Tarcic, G., & Yarden, Y. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.22263 · Cited by 12 · see citing works

Overlapping genes in natural and engineered genomes

Wright, B. W., Molloy, M. P., & Jaschke, P. R. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00417-w · Cited by 137 · see citing works

Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells

Pelosi, E., Castelli, G., & Testa, U. (2017) · Biomedicines · doi:10.3390/biomedicines5040065 · Cited by 124 · see citing works

Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells

Breunig, M., Merkle, J., Wagner, M., Melzer, M. K., Barth, T. F. E., Engleitner, T., Krumm, J., Wiedenmann, S., Cohrs, C. M., Perkhofer, L., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.03.005 · Cited by 110 · see citing works

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer

Stefanoudakis, D., Frountzas, M., Schizas, D., Michalopoulos, N. V., Drakaki, A., & Toutouzas, K. G. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040177 · Cited by 110 · see citing works

WNT inhibition creates a BRCA‐like state in Wnt‐addicted cancer

Kaur, A., Sepramaniam, S., Lim, J. Y. S., Patnaik, S., Harmston, N., Lee, M. A., Petretto, E. G., Virshup, D. M., & Madan, B. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013349 · Cited by 62 · see citing works

The interplay between noncoding RNAs and insulin in diabetes

Tian, Y., Xu, J. M., Du, X., & Fu, X. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.038 · Cited by 55 · see citing works

Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection

Jolissaint, J. S., Soares, K. C., Seier, K. P., Kundra, R., Gönen, M., Shin, P. J., Boerner, T., Sigel, C., Madupuri, R., Vakiani, E., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0412 · Cited by 55 · see citing works

Integrated Machine Learning and Single-Sample Gene Set Enrichment Analysis Identifies a TGF-Beta Signaling Pathway Derived Score in Headneck Squamous Cell Carcinoma

Wu, S., Lv, X., Li, Y., Gao, X., Ma, Z., Fu, X., & Li, Y. (2022) · Journal of Oncology · doi:10.1155/2022/3140263 · Cited by 52 · see citing works

NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling

Verma, S. K., Crawford, D., Khateb, A., Feng, Y., Sergienko, E. A., Pathria, G., Ma, C.-T., Olson, S. H., Scott, D. A., Murad, R., et al. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00985-x · Cited by 50 · see citing works

The role of TGF-β in the tumor microenvironment of pancreatic cancer

Luo, Q., Hu, Z., Zhao, H., Fan, Y., Tu, X., Wang, Y., & Liu, X. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.10.019 · Cited by 44 · see citing works

The Cell Cycle-Associated Protein CDKN2A May Promotes Colorectal Cancer Cell Metastasis by Inducing Epithelial-Mesenchymal Transition

Shi, W., Li, Y., Bai, X., & Lin, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.834235 · Cited by 41 · see citing works

METTL3 promotes cellular senescence of colorectal cancer via modulation of CDKN2B transcription and mRNA stability

Chen, Z., Zhou, J., Wu, Y., Chen, F., Li, J., Tao, L., Tian, Y., Wang, H., Li, Z., Li, Z., et al. (2024) · Oncogene · doi:10.1038/s41388-024-02956-y · Cited by 40 · see citing works

A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas

Wang, X., Su, W., Gao, Y., Feng, Y., Wang, X., Chen, X., Hu, Y., Ma, Y., Ou, Q., Liang, D., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.279908 · Cited by 37 · see citing works

CIP/KIP and INK4 families as hostages of oncogenic signaling

Csergeová, L., Krbušek, D., & Janoštiak, R. (2024) · Cell Division · doi:10.1186/s13008-024-00115-z · Cited by 29 · see citing works

PTEN regulates adipose progenitor cell growth, differentiation, and replicative aging

Kirstein, A. S., Kehr, S., Nebe, M., Hanschkow, M., Barth, L. A. G., Lorenz, J., Penke, M., Breitfeld, J., Duc, D. L., Landgraf, K., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100968 · Cited by 28 · see citing works

Co‐occurrence of CDKN2A/B and IFN‐I homozygous deletions correlates with an immunosuppressive phenotype and poor prognosis in lung adenocarcinoma

Peng, Y., Chen, Y., Song, M., Zhang, X., Li, P., Yu, X., Huang, Y., Zhang, N., Ji, L., Xia, L., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13206 · Cited by 26 · see citing works

Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions

Ottaiano, A., Circelli, L., Santorsola, M., Savarese, G., Fontanella, D., Gigantino, V., Mauro, A. D., Capuozzo, M., Zappavigna, S., Lombardi, A., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13122 · Cited by 25 · see citing works

Reciprocal Regulation between lncRNA ANRIL and p15 in Steroid-Induced Glaucoma

Wan, P., Huang, S., Luo, Y., Deng, C., Zhou, J., Long, E., & Zhuo, Y. (2022) · Cells · doi:10.3390/cells11091468 · Cited by 22 · see citing works

Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns

Mateo, L., Duran‐Frigola, M., Gris‐Oliver, A., Palafox, M., Scaltriti, M., Razavi, P., Chandarlapaty, S., Arribas, J., Bellet, M., Serra, V., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00774-x · Cited by 22 · see citing works

A new method of identifying glioblastoma subtypes and creation of corresponding animal models

Zhou, X., Li, G., An, S., Li, W., Yang, H., Guo, Y., Dai, Z., Dai, S., Zheng, J., Huang, J., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0305-1 · Cited by 17 · see citing works

A functional variant rs1537373 in 9p21.3 region is associated with pancreatic cancer risk

Zhu, B., Zhu, Y., Tian, J., Shen, N., Li, J., Lou, J., Ke, J., Yang, Y., Gong, Y., Gong, J., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.22968 · Cited by 17 · see citing works

miR-29b restrains cholangiocarcinoma progression by relieving DNMT3B-mediated repression of CDKN2B expression

Cao, K., Li, B., Zhang, Y., Song, H., Chen, Y.-G., Gong, Y., Li, H., & Zuo, S. (2021) · Aging · doi:10.18632/aging.202549 · Cited by 15 · see citing works

A novel pancreatic cancer model originated from transformation of acinar cells in adult tree shrew, a primate-like animal

Tu, Q., Yang, D., Zhang, X., Jia, X., An, S., Yan, L., Dai, H., Ma, Y., Tang, C., Tong, W., et al. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.038703 · Cited by 15 · see citing works

Proteomics in pancreatic cancer

Cai, F., Gu, Y., Ling, Y., Yi, G., Zang, S., Su, T., Liu, Y., Li, A., Wang, D., Zhao, W., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00805-y · Cited by 14 · see citing works

p15INK4B is an alternative marker of senescent tumor cells in colorectal cancer

Park, S. S., Lee, Y., Park, S. H., Lim, S. B., Choi, Y. W., Shin, J. S., Kim, Y. H., Kim, J., & Park, T. J. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13170 · Cited by 14 · see citing works

RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma

Tu, Q., Liu, X., Yao, X., Li, R., Liu, G., Jiang, H., Li, K., Chen, Q., Huang, X., Chang, Q., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02490-3 · Cited by 14 · see citing works

Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells

Cheng, X.-Y., Liu, Z., Li, S., Cai, H., Zhang, Y., Cai, Y., Xu, X., Hao, J., & Wang, M. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s151953 · Cited by 14 · see citing works

Loss of chromosome 9p21 is associated with a poor prognosis in adenosquamous carcinoma of the pancreas

Jiang, Y., Wu, Y., Zhang, L., Wang, Y., Xu, G., Deng, Y., Han, L., Li, E., Ma, Q., Xu, M., et al. (2023) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbad030 · Cited by 11 · see citing works

Cyclin-Dependent Kinase Inhibitor 2b Controls Fibrosis and Functional Changes in Ischemia-Induced Heart Failure via the BMI1-p15-Rb Signalling Pathway

Yang, W., Zhang, A., Han, Y., Su, X., Chen, Y., Zhao, W., Yang, K., & Jin, W. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.05.016 · Cited by 11 · see citing works

Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study

Monteiro, F. S. M., Alencar, A. M., da Trindade, K. M., Rebelatto, T. F., Maluf, F. C., Gazola, A. A., Barrios, P. M., Joaquim Bellmunt, B., de Jesus, R. G., Silva, G. E. B., et al. (2024) · The Oncologist · doi:10.1093/oncolo/oyae220 · Cited by 10 · see citing works

Comprehensive Pan-Cancer Analysis of Senescence With Cancer Prognosis and Immunotherapy

Zhao, Q., Hu, W., Xu, J., Zeng, S., Xi, X., Chen, J., Wu, X., Hu, S., & Zhong, T. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.919274 · Cited by 9 · see citing works

Screening of potential novel candidate genes in schwannomatosis patients

Perez‐Becerril, C., Wallace, A. J., Schlecht, H., Bowers, N. L., Smith, P., Gokhale, C., Eaton, H., Charlton, C., Robinson, R., Charlton, R. S., et al. (2022) · Human Mutation · doi:10.1002/humu.24424 · Cited by 9 · see citing works

Development of a TGF-β signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma

Wu, X., Xie, W., Gong, B., Fu, B., Chen, W.-M., Zhou, L., & Luo, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1124080 · Cited by 9 · see citing works

Cyclin-dependent kinase inhibitor 2B gene is associated with the sensitivity of hepatoma cells to Sorafenib

Weng, X., Zeng, L., Yan, F., He, M., Wu, X., & Zheng, D. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s196607 · Cited by 9 · see citing works

Circular RNAs in pancreatic cancer progression

Bao, H., Li, J., Dong, Q., Liang, Z., Yang, C., & Xu, Y. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117633 · Cited by 7 · see citing works

Elevated methylation of cyclin dependent kinase inhibitor 2B contributes to the risk of coronary heart disease in women

Chen, X., Jiang, D., Xu, L., Han, L., Hu, H., Huang, Y., Lu, D., Ji, H., Li, B., Yang, Y., et al. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6920 · Cited by 7 · see citing works

Moving Towards Dawn: KRas Signaling and Treatment in Pancreatic Ductal Adenocarcinoma

Bhattacharya, S., & Rajpurohit, T. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220128161647 · Cited by 6 · see citing works

Exploring the OncoGenomic Landscape of cancer

Mateo, L., Guitart-Pla, O., Duran‐Frigola, M., & Aloy, P. (2018) · Genome Medicine · doi:10.1186/s13073-018-0571-0 · Cited by 6 · see citing works

Sequence Neighborhoods Enable Reliable Prediction of Pathogenic Mutations in Cancer Genomes

Banerjee, S., Raman, K., & Ravindran, B. (2021) · Cancers · doi:10.3390/cancers13102366 · Cited by 5 · see citing works

Construction of a Novel Oxidative Stress Response-Related Gene Signature for Predicting the Prognosis and Therapeutic Responses in Hepatocellular Carcinoma

Hong, J., & Cai, X. (2022) · Disease Markers · doi:10.1155/2022/6201987 · Cited by 4 · see citing works

The utility of molecular studies on pancreatic cystic lesions: A comprehensive review

Xia, R., Liu, X., Hajdu, C. H., Cao, W., Kaz, J. N., Gonda, T. A., & Simsir, A. (2024) · Human Pathology Reports · doi:10.1016/j.hpr.2024.300741 · Cited by 3 · see citing works

A Multiomics Graph Database System for Biological Data Integration and Cancer Informatics

Thapa, I., & Ali, H. (2020) · Journal of Computational Biology · doi:10.1089/cmb.2020.0231 · Cited by 3 · see citing works

The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma

Krog, R. T., de Miranda, N. F. C. C., Vahrmeijer, A. L., & Kooreman, N. G. (2021) · Cancers · doi:10.3390/cancers13225789 · Cited by 3 · see citing works

Smad4 deficiency substitutes Cdkn2b but not Cdkn2a downregulation in pancreatic cancer following induction of genetic events in adult mice

Jia, X., Sun, B., Tu, Q., Qi, H., Li, L., Liu, X., Yan, L., Dai, H., Kong, Q., Tang, C., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.01.004 · Cited by 3 · see citing works

PTEN regulates adipocyte progenitor growth, differentiation and replicative agingPreprint

Kirstein, A. S., Kehr, S., Nebe, M., Hanschkow, M., Lorenz, J., Penke, M., Breitfeld, J., Duc, D. L., Landgraf, K., Körner, A., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.05.425433 · Cited by 3 · see citing works

Challenges and Progress for Treatment of Malignant Peripheral Nerve Sheath Tumors in the Context of Recent Successes for Sarcoma Therapy

Callaghan, J. F., & Mattingly, R. R. (2025) · Cancers · doi:10.3390/cancers17233781 · Cited by 2 · see citing works

Personalized Cancer Therapy Prioritization Based on Driver Alteration Co-occurrence PatternsPreprint

Mateo, L., Duran‐Frigola, M., Gris‐Oliver, A., Palafox, M., Scaltriti, M., Razavi, P., Chandarlapaty, S., Arribas, J., Bellet, M., Serra, V., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/772673 · Cited by 2 · see citing works

A novel induced pluripotent stem cell model of Schwann cell differentiation reveals NF2 - related gene regulatory networks of the extracellular matrixPreprint

Lazaro, O., Li, S., Carter, W., Awosika, O., Robertson, S., Hickey, B. E., Angus, S. P., House, A., Clapp, D. W., Qadir, A. S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.02.591952 · Cited by 2 · see citing works

Efficacy of toripalimab in combination with anlotinib in recurrent undifferentiated pleomorphic sarcoma of the sinonasal region: a case report with biomarker analysis

Wu, F., Feng, J., Wang, H., Wang, S., Cui, X., Liu, Y., Yan, L., Ye, K., Thorne, R. F., Zhang, X. D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1541209 · Cited by 1 · see citing works

Transcriptomic profiling of human iPSC-derived Schwann-like cells reveals NF2-regulated gene regulatory networks

Lazaro, O., Li, S., Smiley, J. S., Carter, W., House, A., Awosika, O., Robertson, S., Haskell, A. K., Hinkel, R. D., Hickey, B. E., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-69205-y · Cited by 1 · see citing works

An oxidative stress response gene model for the prediction of prognosis and therapeutic responses in hepatocellular carcinomaPreprint

Cai, X., & Hong, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1142038/v2 · Cited by 1 · see citing works

Tumor cell-intrinsic stress states drive sensitivity to CAR T cell-therapy in pancreatic cancerPreprint

Fröse, J., Chen, E., Whittaker, C. A., Leclerc, P., Doherty, S., Langenbucher, A., Shao, J., Hellinger, R. D., Goulet, D. R., Tammela, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.24.666408 · Cited by 1 · see citing works

Gemcitabine Resistance Elicits a Calcium Dependent Epigenetic Reprogramming in Pancreatic Cancer

Kutschat, A. P. (2021) · doi:10.53846/goediss-8475

An Oxidative Stress Response Gene Model for the Prediction of Prognosis and Therapeutic Responses in Hepatocellular CarcinomaPreprint

Hong, J., & Cai, X. (2021) · Research Square · doi:10.21203/rs.3.rs-1142038/v1

RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinomaPreprint

Tu, Q., Liu, X., Yao, X., Li, R., Liu, G., Jiang, H., Li, K., Chen, Q., Huang, X., Chang, Q., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1799713/v1

Data from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection

Jolissaint, J. S., Soares, K. C., Seier, K. P., Kundra, R., Gönen, M., Shin, P. J., Boerner, T., Sigel, C., Madupuri, R., Vakiani, E., et al. (2023) · doi:10.1158/1078-0432.c.6530417

Expression analysis of cytoskeleton regulator RNA and Cyclin Dependent Kinase Inhibitor 2B genes in breast cancer

Mokhtari, M., Gholipour, M., Eslami, S., Abak, A., Hussen, B. M., Rakhshan, A., & Ghafouri‐Fard, S. (2023) · Human Antibodies · doi:10.3233/hab-220015

BAZ2A-SUV39H1-SMAD2/3-OCT4 regulates stemness, cell cycle exit and chemoresistance in pancreatic ductal adenocarcinomaPreprint

Militi, S., Liu, F., Nibhani, R., Mouti, M. A., Pook, M., Cai, L., Choo, S. W., & Pauklin, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3570401/v1

Additional file 2 of RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma

Tu, Q., Liu, X., Yao, X., Li, R., Liu, G., Jiang, H., Li, K., Chen, Q., Huang, X., Chang, Q., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21129973

Additional file 5 of RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma

Tu, Q., Liu, X., Yao, X., Li, R., Liu, G., Jiang, H., Li, K., Chen, Q., Huang, X., Chang, Q., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21129976

Additional file 3 of RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma

Tu, Q., Liu, X., Yao, X., Li, R., Liu, G., Jiang, H., Li, K., Chen, Q., Huang, X., Chang, Q., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21129974

Additional file 4 of RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma

Tu, Q., Liu, X., Yao, X., Li, R., Liu, G., Jiang, H., Li, K., Chen, Q., Huang, X., Chang, Q., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21129975

Genetic and epigenetic changes of CDKN2A in gastric cancer

Yıldırım, M. E. (2024) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/cmj.1443256

Genetics and biology of pancreatic ductal adenocarcinoma

Jai, M., & Mozdziak, P. E. (2024) · Medical Journal of Cell Biology · doi:10.2478/acb-2024-0006

Novel structural variants that impact cell cycle genes are elucidated in metastatic gastrointestinal stromal tumors

la Mora, J. D.-D., Assaad, M. A., Quitian, S., Levine, M. F., Deshpande, A. S., Sigouros, M., Manohar, J., Medina-Martinez, J. S., Sboner, A., Elemento, O., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155782

Additional file 1 of RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma

Tu, Q., Liu, X., Yao, X., Li, R., Liu, G., Jiang, H., Li, K., Chen, Q., Huang, X., Chang, Q., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21129972

Hyperprogressive disease in carcinoma induced by immune checkpoint inhibitor therapy: a systematic review

Xu, J., Ni, C., Qin, L., Wang, P., & Xu, J. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04330-8

Large-scale pleiotropic analysis across cancers reveals shared genetic mechanisms and identifies novel functional genes

Wu, X., Yan, Y., Cao, W., Tian, W., He, J., Wang, D., Gong, J., & Niu, X. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag479

Comparative Genomic and Epigenetic Landscape of Histone H3.3 G34R and K27M-Mutated Pediatric High-Grade Glioma Suggests Divergent Precision Oncology StrategiesPreprint

Islam, Z., Zhou, L., & El‐Deiry, W. S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.14.751433

Tumor cell–intrinsic stress states drive sensitivity to CAR T cell therapy in pancreatic cancer

Fröse, J., Chen, E., Whittaker, C. A., Leclerc, P., Doherty, S., Langenbucher, A., Shao, J., Hellinger, R. D., Goulet, D. R., Tammela, T., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeh8973 · Cited by 1 · see citing works

Smad4 deficiency substitutes Cdkn2b but not Cdkn2a downregulation in pancreatic cancer following induction of genetic events in adult mice

Jia, X., Sun, B., Tu, Q., Qi, H., Li, L., Liu, X., Yan, L., Dai, H., Kong, Q., Tang, C., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.01.004 · Cited by 3 · see citing works

Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics

Singh, S. K., & Ellenrieder, V. (2013) · Gut · doi:10.1136/gutjnl-2012-302793 · Cited by 28 · see citing works

Deletion of Rb Accelerates Pancreatic Carcinogenesis by Oncogenic Kras and Impairs Senescence in Premalignant Lesions

Carrière, C., Gore, A. J., Norris, A. M., Gunn, J. R., Young, A. L., Longnecker, D. S., & Korc, M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.041 · Cited by 75 · see citing works

Important role of Nfkb2 in the KrasG12D-driven carcinogenesis in the pancreas

Hassan, Z., Schneeweis, C., Wirth, M., Müller, S., Geismann, C., Neuß, T., Steiger, K., Krämer, O. H., Schmid, R. M., Rad, R., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.03.012 · Cited by 5 · see citing works

The Role of Oncogenic Kras in Pancreatic Cancer Progression and Maintence.

Collins, M. A. (2014) · Deep Blue (University of Michigan)